CAS: 439081-18-2 - N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide

Formule : C₂₄H₂₅ClFN₅O₃

InChI : InChI=1S/C24H25ClFN5O3/c1-31(2)8-3-4-23(32)30-21-11-17-20(12-22(21)34-16-7-9-33-13-16)27-14-28-24(17)29-15-5-6-19(26)18(25)10-15/h3-6,10-12,14,16H,7-9,13H2,1-2H3,(H,30,32)(H,27,28,29)/t16-/m0/s1

Code InChI : InChIKey=ULXXDDBFHOBEHA-INIZCTEOSA-N

SMILES : O=C(C=CCN(C)C)NC1=CC=2C(=NC=NC2NC3=CC=C(F)C(Cl)=C3)C=C1OC4COCC4

Synonymes :

• (2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl}-4-(dimethylamino)but-2-enamide
• (E)-N-(7-((S)-tetrahydrofuran-3-yloxy)-4-(3-chloro-4-fluorophenylamino)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
• (S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-dime
• 2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-
• Afatinib
• Bibw 2992
• Bibw2992
• N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide
• Tovok

N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide

CAS : 439081-18-2

• Formule : C₂₄H₂₅ClFN₅O₃
• Degré de pureté : 98%
• Couleur et forme : Solid
• Masse moléculaire : 485.9384

(S)-Afatinib

CAS : 439081-18-2

(S)-Afatinib (BIBW2992) is an irreversible EGFR family inhibitor with IC50s of 0.5/0.4/10/14/1 nM for EGFRwt, …

• Formule : C₂₄H₂₅ClFN₅O₃
• Degré de pureté : 100% - 99.96%
• Couleur et forme : Off-White Solid
• Masse moléculaire : 485.94

Afatinib

CAS : 439081-18-2

(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide

CAS : 439081-18-2

LFM-A13 is a small molecule that has shown potential to be a biomarker for cancer. …

• Formule : C₂₄H₂₅ClFN₅O₃
• Degré de pureté : Min. 95%
• Masse moléculaire : 485.95 g/mol